Bukwang Inc.
Active in EUDAMEDSouth Koreafrom SRN EUDAMED SRN KR-MF-000044591
Bukwang Inc. is a medical device manufacturer based in South Korea, with 1 device listed in EUDAMED (EU Class I) as of 18 Nov 2026.
- Devices
- 1
- Registrations
- EUDAMED
Registry facts
- Registries
- EUDAMED 1
- Device classes
- EU Class I 1
- Top EMDN categories
- Sites and related companies
- SOAR & PARTNERS Sp. z o.o. authorised representative
- Identifiers
- EUDAMED SRN KR-MF-000044591
At a glance
Market reach
- European Union
- EUDAMED actor
- Authorised rep.
- SOAR & PARTNERS Sp. z o.o.PL
What Bukwang Inc. makes
Bukwang Inc. manufactures DuoSil, a medical device designed for use in orthopedic and spinal applications, likely as a surgical implant or fixation system for bone stabilization.
The company’s portfolio is classified under Class I devices in the EU and is registered in the eudamed database. Bukwang Inc. is based in South Korea.
Catalogue
- Regimes: CE MDR Registry: EUDAMED
Company details
- EUDAMED SRN
- KR-MF-000044591
- EU VAT number
- 6033061782
- EUDAMED status
- Active
- EUDAMED registered name
- Bukwang Inc.
- EUDAMED abbreviated name
- Bukwang
- Registered address
- 224, Jangpyeong-ro, 49444, Busan, South Korea
- Website
- www.bkstar.co.kr
- bkstars@daum.net
- Phone
- +82 51 261 7591
- PRRC contact
- Eunsik Jung
Frequently asked questions
How many devices does Bukwang Inc. have in the registry?
The registry currently lists 1 device for Bukwang Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Bukwang Inc.'s devices?
Among its 1 most recently registered device, Bukwang Inc. has devices listed in EUDAMED (1 device).
What risk classes do Bukwang Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Bukwang Inc.'s devices are Class I. Each device page shows its own class and authorisation.
What are the newest devices from Bukwang Inc. in the registry?
The most recently registered devices listed for Bukwang Inc. include DuoSil.